LONDON, GB / ACCESS Newswire / February 19, 2025 / Helium One Global (AIM:HE1), the primary helium explorer in Tanzania with a 50% working interest in the Galactica-Pegasus helium development project in Colorado, USA ("the Galactica Project"), provides an update following the Blue Star Helium (ASX:BNL) ("Blue Star") announcement issued today regarding the Galactica Project. […]

(NYSE:EGY),(LSE:EGY), HOUSTON, Feb. 19, 2025 (GLOBE NEWSWIRE) — VAALCO Energy, Inc. (NYSE: EGY; LSE: EGY) (“Vaalco” or the “Company”) today announced that it declared its quarterly cash dividend of $0.0625 per share of common stock for the first quarter of 2025 ($0.25 annualized), which is payable on March 28, 2025, to stockholders of record at

(NYSE MKT:CMCL),(LSE – AIM:CMCL),(LSE:CMCL.L),(LSE:CMCL.LN), ST HELIER, Jersey, Feb. 19, 2025 (GLOBE NEWSWIRE) — Caledonia Mining Corporation Plc (“Caledonia” or “the Company”) (NYSE AMERICAN, AIM and VFEX: CMCL) announces that its Chief Financial Officer (“CFO”), Chester Goodburn, will step down from his role on 24 March 2025, following the publication of Caledonia's financial results for the

Tetragon will host a conference call for investors on Wednesday, 5 March 2025 at 15:30 GMT / 10:30 EST to discuss its annual report and to provide a company update. During the call, Tetragon's investment manager will also seek to address questions raised by investors, including questions e-mailed to ir@tetragoninv.com. Getting Access to the Call

Goldman Sachs' latest report on China's biotechnology sector highlights Everest Medicines (1952.HK) as a company on track to achieve EBITDA break-even by the end of 2025. This outlook is driven by the accelerated commercialization of Nefecon(R), which was recently included in China's National Reimbursement Drug List (NRDL). The report underscores that expanded reimbursement coverage is

(Paris:VIRI),(NYSE:CGG), Paris, France – February 19, 2025 Fourth Quarter 2024 & Full Year 2024 financial results and conference call Viridien will announce its fourth quarter & full year 2024 financial results on Thursday, February 27th, after market close. The press release and the presentation will be made available on our website www.viridiengroup.com at 5:45 pm

(Paris:SAN), Sanofi and CD&R sign Opella share purchase agreement Paris, February 19, 2025. Following completion of the required social and corporate procedures, Sanofi and CD&R announce today they have signed the share purchase agreement in relation to the sale of a 50% controlling stake in Opella to CD&R. Bpifrance is expected to participate as a

Nissin Foods (Hong Kong) Charity Fund ('Charity Fund') announced its continued support for elite athletes from The Education University of Hong Kong (EdUHK) for the third consecutive year. The Presentation Ceremony for Nissin Foods Scholarship for Elite Athletes 2024/2025 was held to present scholarships for seven outstanding athletes, who not only excel in their sports

The shares in FlexLNG Ltd. (Ticker: FLNG) traded on Oslo Stock Exchange (“OSE”) and registered with Euronext Securities Oslo will trade ex-dividend of USD 0.75 per share as of today, February 19, 2025. The dividend will be paid to shareholders on OSE on or about March 10, 2025. The shares traded on the New York

KUALA LUMPUR, MALAYSIA / ACCESSWIRE / February 19, 2025 / Saliran Group Berhad ("Saliran" or the "Company"), an established supplier and distributor of pipes, fittings and flanges as well as related parts and accessories, and steel products, is pleased to announce the launch of its prospectus for the Initial Public Offering ("IPO") in conjunction with